Insilico Medicine Clinics

End-to-end generative AI-driven biotech companyWe are a globally leading end-to-end generative AI-driven biotech company in terms of AIDD pipeline progress, with a mission to accelerate drug discovery and development by leveraging our rapidly evolving, proprietary platform across biology, chemistry and clinical | Insilico /?

Invests into

Investors

Connections

Connections from

Founded Date: 2014
Employee Number: 101-250
Number Of Exists: 11-50
Headquarters: Hong Kong
Technology: Biotechnology
Register and Claim Ownership